Bexarotene as maintenance treatment after other than skin-directed therapy in advanced stage mycosis fungoides: a pilot study

Advanced-stage mycosis fungoides (MF) and Sézary Syndrome (SS) patients have a poor quality of life and quickly relapse irrespective of the administered treatment. Most of the available therapies do not warrant long-lasting remission. In the last ten years, the need for an MF maintenance treatment h...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the European Academy of Dermatology and Venereology 2019-05
Main Authors: Pileri, A, Fava, P, Fuligni, F, Gunnella, S, Guglielmo, A, Astrua, C, Grandi, V, Simontacchi, G, Patrizi, A, Quaglino, P, Pimpinelli, N
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Advanced-stage mycosis fungoides (MF) and Sézary Syndrome (SS) patients have a poor quality of life and quickly relapse irrespective of the administered treatment. Most of the available therapies do not warrant long-lasting remission. In the last ten years, the need for an MF maintenance treatment has been investigated in the literature, with most of experiences focusing on the early stages and a few on the advanced phases [2,4]. Encouraging results on the chances of achieving lasting responses after the treatment have been reported in patients on Brentuximab Vedotin. This article is protected by copyright. All rights reserved.
ISSN:1468-3083
DOI:10.1111/jdv.15661